Evidence map›Paper›PMID 41251372›Full record

ArticleAntimicrobial agents and chemotherapy2025

Carbapenems versus non-carbapenems as definitive treatment for hypervirulent

Chih-Han Juan, Sheng-Hua Chou, Chien Chuang, Shih-Neng Lin, Xin-Ni Wu, Szu-Yu Liu, Yu-Chien Ho, Yi-Tsung Lin

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it.

  1. Risk factors for invasiveFrontiers in cellular and infection microbiology · 2026
    Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Chih-Han JuanDivision of Infectious Diseases, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.ORCID 0009-0000-5130-4619
Sheng-Hua ChouDivision of Infectious Diseases, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
Chien ChuangDivision of Infectious Diseases, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
Shih-Neng LinSchool of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.
Xin-Ni WuSchool of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.
Szu-Yu LiuDivision of Infectious Diseases, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
Yu-Chien HoDivision of Infectious Diseases, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
Yi-Tsung LinDivision of Infectious Diseases, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.ORCID 0000-0001-9940-7529

Funding

Ministry of Science and Technology MOST 111-2314-B-A49-044Ministry of Science and Technology NSTC 112-2314-B-A49-029 and NSTC 114-2314-B-A49-079-MY3Szu-Yuan Research Foundation of Internal MedicineTaipei Veterans General Hospital V114C-047Taipei Veterans General Hospital-National Yang-Ming University Excellent Physician Scientists Cultivation Program 106-V-B-027
6 · The paper itself

Abstract

Hypervirulent

Indexed as

Anti-Bacterial AgentsBacteremiaCarbapenemsKlebsiella InfectionsKlebsiella pneumoniaeAgedAged, 80 and overFemaleHumansMaleMicrobial Sensitivity TestsMiddle AgedRetrospective StudiesTaiwanAnti-Bacterial AgentsCarbapenemsbacteremiacarbapenemhypervirulentKlebsiella pneumoniae

Identifiers

PMID41251372
PMCPMC12691612

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.